PSI CRO has opened doors at a new office in The San Francisco Bay Area, USA. This way, PSI remains close to Bay Area biotech and pharmaceutical companies while meeting their growth and business needs by expanding into larger, spacious premises.
PSI CRO AG, a contract research organization, provides clinical trial services in various therapeutic areas in Germany and internationally. Its services include clinical supply management, data management, feasibility, medical affairs, medical writing, monitoring, pharmacovigilance, project management, quality management, regulatory, statistics, and trial support services. The company provides clinical trial services in therapeutic areas, such as cardiology, central nervous system, endocrine and metabolic disease, gastroenterology, hematology and oncohematology, infectious diseases, nephrology and urology, oncology, pediatrics, rare disease, and respiratory, as well as allergy, immunology, and rheumatology. PSI CRO AG was founded in 1995 and is based in Zug, Switzerland.
In 2017, PSI CRO announced additional office openings globally. The company has also recently opened offices in Taiwan, Korea, and Australia. Since its inception in 1995, PSI has remained a private company fully owned by its founders and has grown organically to include more than 50 locations globally and 1,700 staff.